Scoring System Evaluation For Orbital Exenteration In Patients With Rhino-Orbito-Cerebral Mucormycosis

dc.contributor.authorUlas, B.
dc.contributor.authorKursun, E.
dc.contributor.authorTurunc, T.
dc.contributor.authorDemiroglu, Y. Z.
dc.contributor.authorPelit, A.
dc.contributor.orcIDhttps://orcid.org/0000-0002-0722-6964en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-0662-2033en_US
dc.contributor.pubmedID34823889en_US
dc.contributor.researcherIDF-2809-2015en_US
dc.date.accessioned2022-11-11T07:20:54Z
dc.date.available2022-11-11T07:20:54Z
dc.date.issued2022
dc.description.abstractPurpose. - To evaluate our patients with rhino-orbito-cerebral mucormycosis according to a new scoring system and to compare those who underwent orbital exenteration persuant to a new threshhold. Methods. - Mucormycosis is a fungal disease that can be of acute onset, aggressive, and angioinvasive. Aggressive surgical debridement, long-term systemic antifungal therapy, and treatment of underlying predisposing factors are essential to the treatment. However, orbital exenteration is a very difficult decision to make, particularly in patients with orbital involvement, because there is little information in the literature, resulting in limited support for making this aggressive surgical decision. In this study, our 43 cases of mucormycosis were evaluated in terms of orbital exenteration using a scoring system (including clinical signs and symptoms, ophthalmoscopic findings, and radiologic results) developed by Shah et al., which establishes indications for orbital exenteration in mucormycosis. Results. - According to our study, if the threshold score for exenteration is 19.0, the sensitivity was 100% and specificity was 97%, providing better results than the 23.0 threshold score determined by the reference study for exenteration. When these two score thresholds were compared, there was a statistically significant difference. Conclusion. - We believe that this scoring system may be beneficial to use for orbital exenteration in patients with mucormycosis. Prospective studies in large case series are required to determine the most appropriate threshold score. (C) 2021 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.endpage52en_US
dc.identifier.issn0181-5512en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85119615632en_US
dc.identifier.startpage47en_US
dc.identifier.urihttp://hdl.handle.net/11727/8054
dc.identifier.volume45en_US
dc.identifier.wos000741456400023en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.jfo.2021.07.008en_US
dc.relation.journalJOURNAL FRANCAIS D OPHTALMOLOGIEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMucormycosisen_US
dc.subjectExenterationen_US
dc.subjectScoring systemen_US
dc.titleScoring System Evaluation For Orbital Exenteration In Patients With Rhino-Orbito-Cerebral Mucormycosisen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: